“Producing new addiction treatments is essential, but it is equally important to rigorously examine ways to put into action these treatments so that they allow it to be to the health practitioner’s Office environment and get to the individuals who need to have them,” explained NIDA Deputy Director Wilson M.We’ve shared the data, now sharing